Recent pilot clinical studies have demonstrated that subjects with severe disorders of movement and communication can exert direct neural control over assistive devices using invasive Brain-Machine Interface (BMI) technology, also referred to as 'cortical neuroprosthetics'. These important proof-of-principle studies have generated great interest among those with disability and clinicians who provide general medical, neurological and/or rehabilitative care. Taking into account the perspective of providers who may be unfamiliar with the field, we first review the clinical goals and fundamentals of invasive BMI technology, and then briefly summarize the vast body of basic science research demonstrating its feasibility. We emphasize recent translational progress in the target clinical populations and discuss translational challenges and future directions.
Introduction
Over the past decade, as the rate and sophistication of research involving invasive Brain-Machine Interface (BMI) has grown, so has its visibility to clinicians, the disabled and the general public. While the term BMI may encompass a wide array of methods and approaches (Andersen et al., 2010; Ethier et al., 2015; Moxon and Foffani, 2015; Nicolelis and Lebedev, 2009; Schwartz, 2004; Silvoni et al., 2011 ), we will focus on "motor BMIs", i.e. a neural interface that allows direct neural control of a prosthetic device or a communication interface (Bensmaia and Miller, 2014; Homer et al., 2013; Nicolelis and Lebedev, 2009; Schwartz, 2004; Shenoy and Carmena, 2014) . Communication interfaces typically fall into two categories: (1) direct neural control of a cursor for navigation of a computer or use of an optimized keyboard for typing (i.e. sending messages and/or emails) and (2) control of a speech synthesizing prosthetic (Brumberg et al., 2011; Guenther et al., 2009; Hochberg et al., 2006; Kennedy et al., 2000; Mugler et al., 2014) . A motor BMI operates by recording a neural signal, processing that signal into device commands, and sending commands to a device; the user typically receives natural visual feedback regarding the outcome (Fig. 1) . In this review we will specifically focus on invasive approaches using either multielectrode arrays (MEAs) (Bensmaia and Miller, 2014; Homer et al., 2013; Nicolelis and Lebedev, 2009; Schwartz, 2004) or electrocorticography (ECoG) (Fig. 2) (Chang et al., 2010; Crone et al., 1998a Crone et al., , 1998b Ganguly et al., 2009; Leuthardt et al., 2004; Schalk et al., 2008; Vansteensel et al., 2010) ; a main reason for this is that the most recent translational trials demonstrating complex control of prosthetic devices have relied on decoding using invasive approaches (Collinger et al., 2013b; Hochberg et al., 2012) . Hereafter, we will broadly refer to invasive recordings using MEAs or ECoG with the term "cortical neuroprosthetics". Importantly, we do wish to note, however, that there is very active research into the use of non-invasive EEG Neurobiology of Disease 83 (2015) 154-160 
